IMPORTANT NOTE:
If you have the following AUTOIMMUNE DISEASES, you can not qualify for our studies. |
|
To prepare for your visit, you’ll receive an email from Datacapt. Subject line will be: · If YOU are New to Datacapt: [SGS] Welcome to SGS’s Datacapt Platform! · If YOU are Already Registered: [Study Number] – Informed Consent Paperwork The email includes links to: · Informed Consent · Medical History (emailed after IC) · Health & Eligibility (emailed after Medical History) If it’s your first time, create a password using your email as your username. Important: All forms must be completed before your appointment. Incomplete forms may lead to delays or rescheduling.
*******************************************************************************************
If you have the following AUTOIMMUNE DISEASES, you can not qualify for our studies. Here's a list of autoimmune diseases: You will not qualify if you have these! - Alopecia areata: Immune system attacks hair follicles, causing hair loss.
- Addison's disease: Destroys adrenal glands, affecting hormone production.
- Autoimmune hepatitis: Immune system attacks liver cells.
- Celiac disease: Immune response to gluten, causing damage to the small intestine.
- Type 1 diabetes: Immune system attacks cells in the pancreas that produce insulin.
- Graves' disease: Immune system attacks thyroid gland, causing hyperthyroidism.
- Hashimoto's thyroiditis: Immune system attacks thyroid gland, causing hypothyroidism.
- Inflammatory bowel disease (IBD): Affects the digestive tract, including Crohn's disease and ulcerative colitis.
- Multiple sclerosis: Immune system attacks the brain and spinal cord, disrupting nerve function.
- Myasthenia gravis: Immune system attacks nerve-muscle junctions, causing muscle weakness.
- Pernicious anemia: Immune system attacks cells in the stomach that produce a protein needed for B12 absorption.
- Rheumatoid arthritis: Immune system attacks joints, causing inflammation and pain.
- Systemic lupus erythematosus (Lupus): Immune system attacks various organs and tissues.
- Sjögren's syndrome: Immune system attacks glands that produce tears and saliva.
- Vitiligo: Immune system attacks cells that produce pigment in the skin.
- Psoriasis: Immune system causes skin cells to multiply too quickly, leading to scaly, inflamed skin.
- Scleroderma: Immune system attacks connective tissues, causing hardening and damage to skin and other organs.
- Dermatomyositis: Immune system attacks muscles and skin, causing inflammation.
- Polymyositis: Immune system attacks muscles, causing weakness.
- Behcet's disease: Immune system attacks blood vessels, causing inflammation.
- Ankylosing spondylitis: Immune system attacks the spine and other joints, causing inflammation and stiffness.
- Reactive arthritis: Immune system attacks joints after an infection.
No permanent Make up allowed for most FACE study, but there is exception for some FACE study. Please always ask Joanne.
The following are ingredients that products cannot have: - Hyaluronic acid
- Ceramides
- Niacinamide
- Vitamin C
- Retinol
- Peptides
- Alpha-hydroxy acid
- Beta-hydroxy acid
(Lactic acid and citric acid are ok.)
|
|
Study Number: C26-D120 Study Name: GLP- Facial Sagging Break Period: 2 weeks from ANY study |
|
Study Description: This study is to evaluate how the Sponsor's facial serum works over the course of 2 weeks for men and women ages 18-70 years old who have had rapid facial sagging as a result of GLP-1 usage. Gender: Male & Female IMPORTANT= Must have Self Reported STABLE DOSE for at least 4 weeks of GLP1 and currently MUST have STABLE BODY WEIGHT. (Current weekly weight loss not more than 0.5% of body weight at start of GLP1) Age: 18-70 Skin Types: Fitz I-VI Compensation: Up to 230.00 Study Eligibility: - No allergies to skincare products, cosmetics, toiletries, or topical drugs
- Provide proof of GLP medication that includes, legal name, prescribing physician and the date prescribed, name of medication & dosage
- No known reactivity to soybean oil
- Not pregnant/nursing or trying to conceive (self or partner)
- No skin cancer in past 5 years
- No organ transplant history
- No immune/autoimmune conditions (including MS, lupus, HIV) or related meds
- No new long-term meds in past 2 months
No planned surgeries/procedures.
| DATES AND TIMES SUBJECT TO CHANGE | | Total Enrollment 0 / 30 | Visit: 1 Screening | Visit: 2 Baseline | Visit: 3 Hour 48 | Visit: 4 Week 2 |
|
|
|
|
|
|
|
|
|
| | Group: 3 [0] | Mon 11/30/2026 09:00 AM - 10:00 AM | Wed 12/2/2026 09:00 AM - 02:00 PM | Fri 12/4/2026 10:00 AM - 12:00 PM | Thu 12/17/2026 09:00 AM - 12:00 PM | | Group: 4 [0] | Mon 12/7/2026 09:00 AM - 10:00 AM | Wed 12/9/2026 09:00 AM - 02:00 PM | Fri 12/11/2026 10:00 AM - 12:00 PM | Tue 12/22/2026 09:00 AM - 12:00 PM | | Group: 5 [0] | Mon 12/7/2026 03:00 PM - 04:00 PM | Wed 12/9/2026 02:00 PM - 07:00 PM | Fri 12/11/2026 02:00 PM - 04:00 PM | Mon 12/21/2026 03:00 PM - 05:00 PM | TEXT JOANNE 214-395-0600 |
|
Study Number: C26-D110 Study Name: Lash Serum Study Break Period: 4 Weeks from any face study |
|
Study Description: This study is to evaluate how the Sponsor's lash serum works over the course of 16 weeks for women ages 18-65 who have minimum to moderate eyelash visibility. Gender: Female (Caucasian, Asian, Hispanic with Contact lens or Non Contact lens) or African American with Contact lens. Age: 18-65 - Must not be in any Face study past 4 weeks.
ALL panelists must have SPARCE EYELASHES (THIN EYE LASH)
Compensation: Up to $525.00 Study Eligibility: - No skincare or eye care product allergies (eucalyptus, sunflower seed, grape seed, turmeric, radish root, ginseng root, soybean, or apple)
- No permanent eye makeup- Please note!
- No eye surgery within 3 years
- Not pregnant/nursing or trying to conceive (self or partner)
- No cancer in past 5 years
- No organ transplant history
- No immune/autoimmune conditions (including MS, lupus, HIV) or related meds
- No new long-term meds in past 2 months
No planned surgeries/procedures.
| DATES AND TIMES SUBJECT TO CHANGE | | Total Enrollment 0 / 90 | Visit: 1 Baseline | Visit: 2 Week 4 | Visit: 3 Week 8 | Visit: 4 Week 12 | Visit: 5 Week 16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| | Group: 11 [0] | Thu 11/19/2026 03:00 PM - 04:00 PM | Thu 12/17/2026 03:30 PM - 05:30 PM | Thu 1/14/2027 03:00 PM - 05:00 PM | Wed 2/10/2027 03:00 PM - 05:00 PM | Thu 3/11/2027 03:30 PM - 05:30 PM | | Group: 12 [0] | Fri 11/20/2026 10:00 AM - 11:00 AM | Thu 12/17/2026 09:00 AM - 11:00 AM | Fri 1/15/2027 10:00 AM - 12:00 PM | Thu 2/11/2027 09:00 AM - 11:00 AM | Thu 3/11/2027 09:00 AM - 11:00 AM |
|
|
|
|
|
| TEXT JOANNE 214-395-0600 |
|
SUPER EASY STUDY D067 ! 1 VISIT ONLY |
|
Are you interested in another Eye Drop study? Take 3hrs or less. - 1 Visit only. Compensation $100 You can sign up for ALL of the following groups if qualify. Must NOT be in any other study at the same time. RELIABLE PARTICIPANTS only!
D067G START 12/3 Time: 9am or 10am
D067 H START 12/9 Time: 12 noon or 1pm
D067 I START 12/16 Time: 9am or 10am
D067 J START 1/6 Time: 9am or 10am
D067 K START 1/12 Time: 9am or 10am
***QUALIFICATION****
1.Must NOT be in another study.
2.Must have Healthy Eyes. No glaucoma or cataract recently.
3. NO ASTHMA or DIABETES.
4. No lash extensions or fake eye lash.
5. Avoid shampoo to hair 24 hrs prior to visit 1.
 Super easy study!
Please only sign up if you can sure make it.
We only offer this study for our most Reliable participants. We will not consider Anyone that was NO SHOW with us in the past.
|
|
Study Number: C26-D123 Study Name: Dark Spot & Crepiness Break Period: 2 weeks |
|
Study Description: This study is to evaluate how the Sponsor's body product works over the course of 12 weeks for women ages 30 to 70 who have mild to moderate signs of aging or uneven skin tone on the neck, chest, arms, and lower legs. Gender: Female- Must have NO tattoos on arms, chest, neck or legs. Age: 30-70 Skin Types: FITZ-I-VI Compensation: Up to $425.00 Study Eligibility: - No skincare allergies
- No reactivity to topically applied ingredients such as Lavender, rose, sesame seed, cucumber, beets
- Cannot have started GLP-1 in the last 12 months
- Must be able to stand and walk unaided for 15 minutes+
- Not pregnant/nursing or trying to conceive (self or partner)
- No skin cancer in past 5 years
- No organ transplant history
- No immune/autoimmune conditions (including MS, lupus, HIV) or related meds
- No new long-term meds in past 2 months
No planned surgeries/procedures.
| DATES AND TIMES SUBJECT TO CHANGE | | Total Enrollment 0 / 50 | Visit: 1 Baseline | Visit: 2 Week 1 | Visit: 3 Week 4 | Visit: 4 Week 8 | Visit: 5 Week 12 |
|
|
|
|
|
|
|
|
|
|
|
| | Group: 3 [0] | Fri 11/13/2026 10:00 AM - 11:00 AM | Thu 11/19/2026 09:00 AM - 11:00 AM | Thu 12/10/2026 09:00 AM - 11:00 AM | Fri 1/8/2027 10:00 AM - 12:00 PM | Thu 2/4/2027 09:00 AM - 11:00 AM | | Group: 4 [0] | Mon 11/16/2026 03:00 PM - 04:00 PM | Mon 11/23/2026 03:00 PM - 05:00 PM | Mon 12/14/2026 03:00 PM - 05:00 PM | Mon 1/11/2027 03:00 PM - 05:00 PM | Mon 2/8/2027 03:00 PM - 05:00 PM | | Group: 5 [0] | Wed 11/18/2026 09:00 AM - 10:00 AM | Tue 11/24/2026 09:00 AM - 11:00 AM | Wed 12/16/2026 09:00 AM - 11:00 AM | Wed 1/13/2027 09:00 AM - 11:00 AM | Wed 2/10/2027 09:00 AM - 11:00 AM | | Group: 6 [0] | Mon 11/23/2026 09:00 AM - 10:00 AM | Tue 12/1/2026 09:00 AM - 11:00 AM | Wed 12/23/2026 09:00 AM - 11:00 AM | Mon 1/18/2027 09:00 AM - 11:00 AM | Mon 2/15/2027 09:00 AM - 11:00 AM | | Group: 7 [0] | Mon 11/30/2026 03:00 PM - 04:00 PM | Mon 12/7/2026 03:00 PM - 05:00 PM | Wed 12/30/2026 03:00 PM - 05:00 PM | Tue 1/26/2027 03:00 PM - 05:00 PM | Tue 2/23/2027 03:00 PM - 05:00 PM | | Group: 8 [0] | Wed 12/2/2026 03:00 PM - 04:00 PM | Thu 12/10/2026 03:00 PM - 05:00 PM | Tue 12/29/2026 03:00 PM - 05:00 PM | Wed 1/27/2027 03:00 PM - 05:00 PM | Wed 2/24/2027 03:00 PM - 05:00 PM | | Group: 9 [0] | Wed 12/9/2026 09:00 AM - 10:00 AM | Thu 12/17/2026 09:00 AM - 11:00 AM | Wed 1/6/2027 09:00 AM - 11:00 AM | Wed 2/3/2027 09:00 AM - 11:00 AM | Wed 3/3/2027 09:00 AM - 11:00 AM | | Group: 10 [0] | Wed 12/9/2026 03:00 PM - 04:00 PM | Tue 12/15/2026 03:00 PM - 05:00 PM | Mon 1/4/2027 03:00 PM - 05:00 PM | Fri 2/5/2027 02:00 PM - 04:00 PM | Tue 3/2/2027 03:00 PM - 05:00 PM | | Group: 11 [0] | Wed 12/16/2026 03:00 PM - 04:00 PM | Wed 12/23/2026 03:00 PM - 05:00 PM | Wed 1/13/2027 03:00 PM - 05:00 PM | Wed 2/10/2027 03:00 PM - 05:00 PM | Wed 3/10/2027 03:00 PM - 05:00 PM | | Group: 12 [0] | Thu 12/17/2026 03:00 PM - 04:00 PM | Thu 12/24/2026 03:00 PM - 05:00 PM | Thu 1/14/2027 03:00 PM - 05:00 PM | Thu 2/11/2027 03:00 PM - 05:00 PM | Thu 3/11/2027 03:00 PM - 05:00 PM |
|
|
|
|
�� GIVEAWAY ALERT! �� Panelists who update their profile by November 24 can enter for a chance to win a $100 Amazon gift card, with the winner announced Wednesday November 25. �� |
|
Study Number: C26-D075 Break Period: 30 days from any study |
|
Study Description: This study is to evaluate how the Sponsor's facial moisturizer reduces skin sensitivity following a sting test involving mild irritants over the course of 4 weeks for women ages 18-50 years old who have self-perceived sensitive skin. Gender: Female - No study in the past 30 days Age: 18-50 Skin Types: Fitz I-VI Compensation: Up to $250.00 Study Eligibility: - No skincare allergies
- No Diabetes (controlled or uncontrolled)
- No severe acne or skin rash within 14 days
- Cannot be an employee or related to an employee of SGS
- Not pregnant/nursing or trying to conceive (self or partner)
- No cancer in past 5 years
- No organ transplant history
- No immune/autoimmune conditions (including MS, lupus, HIV) or related meds
- No new long-term meds in past 2 months
No planned surgeries/procedures.
| DATES AND TIMES SUBJECT TO CHANGE | | Total Enrollment 0 / 50 | Visit: 1 Screening | Visit: 2 Baseline | Visit: 3 Week 2 | Visit: 4 Week 4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| | Group: 502 [0] | Tue 11/17/2026 09:00 AM - 10:00 AM | Thu 11/19/2026 09:00 AM - 11:00 AM | Thu 12/3/2026 09:00 AM - 11:00 AM | Thu 12/17/2026 09:00 AM - 11:00 AM |
|
|
|
|
| | Group: 601 [0] | Fri 11/20/2026 10:00 AM - 11:00 AM | Mon 11/23/2026 03:00 PM - 05:00 PM | Mon 12/7/2026 03:00 PM - 05:00 PM | Mon 12/21/2026 03:00 PM - 05:00 PM | | Group: 602 [0] | Fri 11/20/2026 02:00 PM - 03:00 PM | Mon 11/23/2026 03:00 PM - 05:00 PM | Mon 12/7/2026 03:00 PM - 05:00 PM | Mon 12/21/2026 03:00 PM - 05:00 PM | | Group: 7 [0] | Mon 11/30/2026 09:00 AM - 10:00 AM | Thu 12/3/2026 03:00 PM - 05:00 PM | Thu 12/17/2026 03:00 PM - 05:00 PM | Thu 12/31/2026 03:00 PM - 05:00 PM | | Group: 701 [0] | Mon 11/30/2026 03:00 PM - 04:00 PM | Thu 12/3/2026 03:00 PM - 05:00 PM | Thu 12/17/2026 03:00 PM - 05:00 PM | Thu 12/31/2026 03:00 PM - 05:00 PM | | Group: 702 [0] | Tue 12/1/2026 03:00 PM - 04:00 PM | Thu 12/3/2026 03:00 PM - 05:00 PM | Thu 12/17/2026 03:00 PM - 05:00 PM | Thu 12/31/2026 03:00 PM - 05:00 PM | | Group: 8 [0] | Mon 12/7/2026 09:00 AM - 10:00 AM | Thu 12/10/2026 09:00 AM - 11:00 AM | Wed 12/23/2026 09:00 AM - 11:00 AM | Wed 1/6/2027 09:00 AM - 11:00 AM | | Group: 801 [0] | Mon 12/7/2026 03:00 PM - 04:00 PM | Thu 12/10/2026 09:00 AM - 11:00 AM | Wed 12/23/2026 09:00 AM - 11:00 AM | Wed 1/6/2027 09:00 AM - 11:00 AM | | Group: 802 [0] | Tue 12/8/2026 09:00 AM - 10:00 AM | Thu 12/10/2026 09:00 AM - 11:00 AM | Wed 12/23/2026 09:00 AM - 11:00 AM | Wed 1/6/2027 09:00 AM - 11:00 AM | | Group: 9 [0] | Mon 12/14/2026 09:00 AM - 10:00 AM | Thu 12/17/2026 09:00 AM - 11:00 AM | Thu 12/31/2026 09:00 AM - 11:00 AM | Thu 1/14/2027 09:00 AM - 11:00 AM | | Group: 901 [0] | Mon 12/14/2026 03:00 PM - 04:00 PM | Thu 12/17/2026 09:00 AM - 11:00 AM | Thu 12/31/2026 09:00 AM - 11:00 AM | Thu 1/14/2027 09:00 AM - 11:00 AM | | Group: 902 [0] | Tue 12/15/2026 09:00 AM - 10:00 AM | Thu 12/17/2026 09:00 AM - 11:00 AM | Thu 12/31/2026 09:00 AM - 11:00 AM | Thu 1/14/2027 09:00 AM - 11:00 AM | TEXT JOANNE 214-395-0600 |
|
| Study Number: C26-AD025 Study Name: Baby Lotion Study Break Period: 2 weeks from any scalp, forearm, or lower leg study |
|
| Study Description: This study is to evaluate how the Sponsor's topical product (daily lotion) works over the course of 28 days for babies. Gender: Males and Females Age: 3 months to 6 months Skin Types: Fitz I-VI Compensation: Up to $200.00 Study Eligibility: - Cannot have any autoimmune disorders, connective tissue diseases, or immune deficiencies (such as lupus, Crohn's disease, HIV, or rheumatoid arthritis).
- Must have been carried to full term at birth (Gestational age ≥ 37 weeks)
- Parent/Guardian must be 18 or older.
| DATES AND TIMES SUBJECT TO CHANGE | | Total Enrollment 0 / 20 | Visit: 1 Baseline | Visit: 2 Day 28 | | Group: 1 [0] | Mon 6/8/2026 03:00 PM - 04:00 PM | Mon 7/6/2026 03:00 PM - 05:00 PM | | Group: 2 [0] | Wed 6/10/2026 09:00 AM - 10:00 AM | Wed 7/8/2026 09:00 AM - 11:00 AM | | Group: 3 [0] | Wed 6/24/2026 09:00 AM - 10:00 AM | Wed 7/22/2026 09:00 AM - 11:00 AM | | Group: 4 [0] | Wed 6/24/2026 03:00 PM - 04:00 PM | Mon 7/20/2026 04:00 PM - 06:00 PM | | Group: 5 [0] | Mon 6/29/2026 03:00 PM - 04:00 PM | Mon 7/27/2026 04:00 PM - 06:00 PM | | Group: 6 [0] | Tue 6/30/2026 03:00 PM - 04:00 PM | Tue 7/28/2026 04:00 PM - 06:00 PM | | Group: 7 [0] | Mon 9/28/2026 03:00 PM - 04:00 PM | Wed 10/28/2026 03:00 PM - 05:00 PM | | Group: 8 [0] | Wed 9/30/2026 09:00 AM - 10:00 AM | Thu 10/29/2026 03:30 PM - 05:30 PM | TEXT JOANNE 214-395-0600 |
|
| Study Number: C26-AD028 Study Name: Baby Lotion Study Break Period: 2 weeks from any face, arm, or leg study | |
|
| Study Description: This study is to evaluate the Sponsor's topical product (daily lotion) works over the course of 28 days for babies and toddlers. Gender: Male and Female Age: 3 months to 6 months old Skin Types: Fitz I-VI Compensation: Up to $200.00 Study Eligibility: - Cannot have any autoimmune disorders, connective tissue diseases, or immune deficiencies (such as lupus, Crohn's disease, HIV, or rheumatoid arthritis).
- Cannot have used any corticosteroids (systemic [affecting whole body] or topical [applied on the skin], not nasal or ocular) within 4 weeks (e.g. Betamethasone, Clobetasol, Desoximetasone, Diflorasone, Fluocinonide, Halcinonide, Halobetasol)
- Cannot have used any antihistamines within the last 1 week (e.g. Diphenhydramine, Hydroxyzine, Cetirizine, Loratadine, Fexofenadine)
- Cannot have used any anti-inflammatory drugs within the last 1 week (e.g. Ibuprofen, Naproxen, Aspirin, Diclofenac, Celecoxib, Meloxicam)
- Must have been carried to full term at birth (Gestational age ≥ 37 weeks)
· Parent or primary caregiver of the child must be at least 18 years of age.
TEXT JOANNE 214-395-0600 |
|
|
|
|
|
|
|